Table 2.
Surgical, pathological, and postoperative outcomes of enrolled patients.
| KD group (n=28) | DV group (n=30) | P | |
|---|---|---|---|
| Success (n, %) | 28 (100) | 30 (100) | – |
| Conversions (n, %) | 0 (0) | 0 (0) | – |
| Duration of operation, min | 200.7 (48.4) | 164.4 (42.9) | 0.004 |
| Docking time, min | 5.5 (2.0) | 6.1 (3.4) | 0.443 |
| Console time, min | 91.7 (50.2) | 74.3 (37.3) | 0.137 |
| Blood loss, ml | 58.9 (52.3) | 54.7 (46.4) | 0.744 |
| Maximum tumor diameter, cm | 3.9 (1.5) | 4.4 (1.8) | 0.288 |
| Number of harvested lymph nodes | 15.3 (7.9) | 16.7 (6.8) | 0.468 |
| Negative margins (n, %) | 56 (100) | 60 (100) | – |
| Time to first flatus, h | 31.3 (17.9) | 33.4 (16.4) | 0.640 |
| Adverse events (n, %) | 4 (14.3) | 2 (6.7) | 0.415 |
| Serious adverse events (n, %) | 2 (7.1) | 2 (6.7) | 1.000 |
| Clavien–Dindo grade II or higher grade, (n, %) | 1 (3.6) | 1 (3.3) | 1.000 |